• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Erleada Reduces Risk of Death in Metastatic Prostate Cancer Subset

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate cancer. Read More

Understanding Esophageal Cancer: Early Signs, Risks and Key Insights

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for those with the disease. Read More

Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome. Read More

Bria-IMT Combo Outperforms Other Metastatic Breast Cancer Treatments

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ metastatic breast cancer. Read More

Sometimes, Distractions Help During Breast Cancer

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles After a mammogram and breast cancer scare, a Broadway show provided a welcome distraction and joy, reminding me of life’s beauty. Read More

Understanding the Use of Bispecific Antibodies in Multiple Myeloma

by | Apr 4, 2025 | Uncategorized

Source: CureToday articles Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles. Read More
« Older Entries
Next Entries »

Recent Content

  • EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
  • Patient-reported physical function has ‘real clinical value’ for treating multiple myeloma
  • Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma
  • The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma
  • FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma
  • FDA accelerates linvoseltamab-gcpt approval for multiple myeloma
  • Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers
  • The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT